Positions
- Professor
-
Pediatrics
Hematology-Oncology
Baylor College of Medicine
Houston, TX, US
- Co-Leader, Cancer Prevention & Population Sciences Program
-
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas, United States
Addresses
- Baylor Clinic (Office)
-
6620 Main Street
BCLN-11D.26
Houston, TX, 77030
United States
Education
- Post-Doctoral Fellowship at University of Texas Health Science Center
- 08/2010 - Houston, Texas, United States
- Genetic Epidemiology
- PhD from University of Texas Health Science Center
- 08/2009 - Houston, Texas, United States
- Epidemiology
- MPH from University of Texas Health Science Center
- 08/2004 - Houston, Texas, United States
- Disease Control
- BS from Houston Baptist University
- 05/1996 - Houston, Texas, United States
- Biology, Political Science
Honors & Awards
- Delta Omega, Honorary Society in Public Health
- (05/2010)
- Pediatric Loan Repayment Program
- National Institutes of Health (10/2011 - 09/2015)
- Research Mentoring Award
- University of Texas School of Public Health (08/2012)
- Kurt Groten Family Research Scholars Award
- (07/2012 - 06/2015)
- Annual Investigator Meeting Travel Award
- Childhood Cancer Survivor Study (06/2013)
- Invited participant, Integrative Molecular Epidemiology Workshop
- American Association for Cancer Research (07/2013)
- “Top Abstracts” recipient
- American Society of Preventive Oncology (03/2014)
- Best Poster
- National Birth Defects Prevention Network 18th Annual Meeting (10/2015)
- Top Scoring Abstracts Award
- 49th Congress of the International Society of Paediatric Oncology (10/2017)
- Best Poster
- National Birth Defects Prevention Network 21st Annual Meeting (03/2018)
- F. Clarke Fraser New Investigator Award
- Teratology Society (06/2018)
Professional Interests
- Cancer epidemiology
- Genetic epidemiology
- Childhood cancer
- Overlap between birth defects and childhood cancer
- Epidemiology of birth defects
Professional Statement
The ultimate goal of my research is to discover factors that can be used in childhood cancer prevention efforts and targeted interventions to limit the adverse consequences of childhood cancer treatment.
Selected Publications
-
Lupo PJ, Nousome D, Kamdar KY, Okcu MF, Scheurer ME. " A case-parent triad assessment of folate metabolic genes and the risk of childhood acute lymphoblastic leukemia. " Cancer Causes Control. 2012 Nov ; 23 (11) : 1797-803.
Pubmed PMID: 22941668. -
Lupo PJ, Symanski E. " A comparative analysis of modeled and monitored ambient hazardous air pollutants in Texas: a novel approach using concordance correlation. " J Air Waste Manag Assoc. 2009 Nov ; 59 (11) : 1278-86.
Pubmed PMID: 19947109. -
Lupo PJ, Chapa C, Nousome D, Duhon C, Canfield MA, Shaw GM, Finnell RH, Zhu H. " A GCH1 haplotype and risk of neural tube defects in the National Birth Defects Prevention Study. " Mol. Genet. Metab.. 2012 Nov ; 107 (3) : 592-5.
Pubmed PMID: 23059057. -
Lupo PJ, Lee LJ, Okcu MF, Bondy ML, Scheurer ME. " An exploratory case-only analysis of gene-hazardous air pollutant interactions and the risk of childhood medulloblastoma. " Pediatr Blood Cancer. 2012 Oct ; 59 (4) : 605-10.
Pubmed PMID: 22389292.
Memberships
- American Association for Cancer Research
- Member (01/2008)
- Childhood Cancer and Leukemia International Consortium
- Member (01/2011)
- Children’s Oncology Group
- Chair, Epidemiology Committee (07/2012)
- International Society of Paediatric Oncology
- Member (01/2015)
- Advisory Committee to the Texas Cancer Registry
- Member (07/2016)
- Society for Birth Defects Research and Prevention
- Member (09/2017)
- National Birth Defects Prevention Network
- Member (01/2008)
Funding
-
Epigenomic Profiling of Metabolic Outcomes in Childhood Leukemia Survivors
#U24CASS727 (Parent grant ID) - $20,000.00 (12/01/2013 - 11/30/2014)
- Grant funding from Childhood Cancer Survivor Study (CCSS)/NCI
-
Exploring the Intersection Between Childhood Cancer and Birth Defects to Identify Novel Cancer Predisposition Syndromes
#Epidemiology Grant - $200,000.00 (07/01/2014 - 06/30/2016)
- Grant funding from Alex's Lemonade Stand Foundation
-
The Intersection between Childhood Cancer and Congenital Anomalies: Identifying Novel Cancer Predisposition Syndromes
#RP140258 - $874,964.00 (08/31/2014 - 08/30/2017)
- Grant funding from Cancer Prevention & Research Institute of Texas (CPRIT)
-
Genetic Epidemiology and Molecular Basis of Cancer Predisposition in Pediatric Rhabdomyosarcoma
#RP170071 - $1,488,105.00 (12/01/2016 - 11/30/2019)
- Grant funding from CPRIT
-
Molecular Epidemiology And Somatic Alterations Driving Acute Lymphoblastic Leukemia In Down Syndrome
#RP170074 - $1,200,000.00 (12/01/2016 - 11/30/2020)
- Grant funding from CPRIT
-
Reducing Ethnic Disparities in Acute Leukemia (REDIAL) Consortium
- $2,000,000.00 (07/01/2017 - 06/30/2021)
- Grant funding from St. Baldrick's Foundation
-
The Early-Life Exposome and Risk of Pediatric Acute Lymphoblastic Leukemia
#RP180755 - $199,140.00 (08/31/2018 - 08/30/2020)
- Grant funding from CPRIT
-
A Multidisciplinary Approach for Identifying and Characterizing Novel Congenital Malformation Syndromes
#R01HD093660 - $1,662,692.00 (08/25/2018 - 06/30/2023)
- Grant funding from NIH/NICHD
-
Genomic Analysis of Congenital Heart Defects and Acute Lymphoblastic Leukemia in Children with Down Syndrome
#X01HL145686 - (10/01/2018 - 09/30/2019)
- Grant funding from NIH
-
Genomic Analysis of Pediatric Rhabdomyosarcoma
#X01HD100852 - (10/01/2019 - 09/30/2020)
- Grant funding from NIH
-
Molecular Epidemiology of Acute Lymphoblastic Leukemia in Children with Down Syndrome
#R01CA249867 - $2,130,791.00 (08/03/2020 - 07/31/2023)
- Grant funding from NIH/NCI
-
Identifying Novel Cancer Predisposition Syndromes: An Integrative Epidemiologic and Genomic Approach
#CA190214 - $1,000,000.00 (08/15/2020 - 08/14/2023)
- Grant funding from DOD
Log In to edit your profile